2021
DOI: 10.3390/v13112183
|View full text |Cite
|
Sign up to set email alerts
|

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2

Abstract: Rapid antigen tests (RATs) for COVID-19 based on lateral flow immunoassays are useful for rapid diagnosis in a variety of settings. Although many kinds of RATs are available, their respective sensitivity has not been compared. Here, we examined the sensitivity of 27 RATs available in Japan for the detection of the SARS-CoV-2 delta variant. All of the RATs tested detected the delta variant albeit with different sensitivities. Nine RATs (ESPLINE SARS-CoV-2, ALSONIC COVID-19 Ag, COVID-19 and Influenza A+B Antigen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 25 publications
1
12
0
Order By: Relevance
“…In many countries, rapid antigen tests (RATs) for the detection of SARS-CoV-2 continue to be a central component of national testing strategies offering quick, inexpensive and laboratory-independent, point-of-care diagnostics. However, the evaluation by independent laboratories [14][15][16][17][18][19][20][21][22][23][24][25] and a Cochrane meta-analysis [26] have indicated a highly variable performance of RATs resulting in an ongoing controversy over these tests' utility for the detection of acute SARS-CoV-2-infected individuals in different settings relevant for clinical diagnosis and containment strategies.…”
Section: Introductionmentioning
confidence: 99%
“…In many countries, rapid antigen tests (RATs) for the detection of SARS-CoV-2 continue to be a central component of national testing strategies offering quick, inexpensive and laboratory-independent, point-of-care diagnostics. However, the evaluation by independent laboratories [14][15][16][17][18][19][20][21][22][23][24][25] and a Cochrane meta-analysis [26] have indicated a highly variable performance of RATs resulting in an ongoing controversy over these tests' utility for the detection of acute SARS-CoV-2-infected individuals in different settings relevant for clinical diagnosis and containment strategies.…”
Section: Introductionmentioning
confidence: 99%
“…The difference in the test LoDs like our study was observed in other reports. For example, a comparative study for the Delta variant reported from Japan showed quite similar findings [ 6 ]. While the most sensitive test was ESPLINE® and ImmunoArrow® in this report, LoDs of the QuickNavi™, Panbio™ and Rapid Antigen Test were 10-fold-higher, and that of ImmunoAce® was 100-fold higher.…”
Section: Discussionmentioning
confidence: 73%
“…Second, RNA levels based on RT‐qPCR were not used to represent the virus amounts. Since RNA levels are correlated with infectious virus titers, 15 this would not affect the interpretation of the results within this paper, but might make it difficult to compare our results with those in other papers. Third, prototype isolates such as Wuhan‐Hu‐1 2019 were not included as a baseline.…”
Section: Discussionmentioning
confidence: 92%
“…Although the sensitivity of RATs is lower than that of RT‐qPCR, 2–9 RATs with a short turnaround time can help improve diagnosis. To this end, we and others previously compared the sensitivity of RATs and found that most RATs show similar sensitivity against ancestral SARS‐CoV‐2, SARS‐CoV‐2 possessing the D614G substitution in its S protein, and the delta variant (lineage B.1.617.2) 9–15 . RAT performance has also been evaluated for Omicron variant detection, including BA.1 and BA.2 16–22 .…”
Section: Introductionmentioning
confidence: 99%